Join
Live feed
·
INSIDERFilingvia Quantisnow
Vistagen Therapeutics Inc. logo

SEC Form 4: Adler Reid G. bought $50,910 worth of shares (300,000 units at $0.17), increasing direct ownership by 866% to 334,629 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTGN (Vistagen Therapeutics Inc.) and more on Quantisnow.